The Global Postpartum Hemorrhage Treatment Device Market size is projected to grow at a CAGR of 8.0% during the forecast period, to reach a revenue of $2.3 billion by 2028 from $1.6 billion in 2017, with an emergence of new product launches and clinical trials driving this growth. The most significant drivers for this growth are the increasing number of deliveries globally and growing awareness about postpartum hemorrhage among women and gynecologists.
Postpartum Hemorrhage Treatment Device can be defined as devices that can be used to stop bleeding after delivery. It may be inserted into the uterus or injected directly into the uterine cavity through an intra-uterine injection system, balloon tamponade, and other methods.
On the basis of Types, the market is segmented into Uterine Balloon Tamponade, Uniject Prefilled Injection System, and Other.
Uterine Balloon Tamponade is a type of device that is used to control postpartum hemorrhage by inflating an intrauterine balloon during the delivery process. These devices are recommended for controlling heavy bleeding and uterine atony, which can cause uterine rupture or other complications.
Uterine Balloon Tamponade is mainly used in the management of postpartum hemorrhage. Other potential applications include: treating uterine atony following a cesarean delivery, which may cause rupture and other complications; to control heavy bleeding with minimal risks during labor or cesarean surgery: for recurrent miscarriage, where it can be inserted if there is an incomplete evacuation after a spontaneous abortion.
Uniject is a pre-filled injection system of oxytocin (a hormone) that can be used in the management of postpartum hemorrhage or uterine atony. The fluid within Uniject has been designed to be delivered by needleless syringe dispensing technology and reconstituted with sterile normal saline, so it does not need to be administered using an infusion pump. It comes as either single-dose vials for emergency use or more commonly, as autoinjection systems which allow up to three doses from one package.
On the basis of Application, the market is segmented into Hospitals, Clinics, and Others.
Hospitals will be the largest application segment in this market. They are used to monitor and treat postpartum hemorrhage, a condition where bleeding occurs after childbirth that can lead to death if not treated immediately. Hospitals or clinics use these devices for the treatment of severe cases of postpartum hemorrhage when uterine balloon tamponade and Uniject Prefilled Injection System do not work effectively. These hospitals have specialized obstetric units with skilled professionals who provide care for women during pregnancy, delivery, as well as assessments for complications following birth which may include postpartum hemorrhaging
Clinics constitute a smaller share than hospitals but important due to their proximity in rural areas. There is an increasing trend in the number of clinics providing postpartum hemorrhage treatment, which is likely to continue due to the shortage of hospitals with obstetric units and skilled personnel.
On the basis of Region, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is one of the fastest-growing markets in this region due to a number of factors such as increasing incidence rates for postpartum hemorrhage complications, technological advancements in the healthcare industry with an emphasis on improving end-user experience; and expansion plans by key players like CareFusion Corporation (Uterine Balloon Tamponade), GlaxoSmithKline plc (Uniject Prefilled Injection System).
Up Market Research published a new report titled “Postpartum Hemorrhage Treatment Device Market research report which is segmented by Types (Uterine Balloon Tamponade, Uniject Prefilled Injection System, Other), By Applications (Hospitals, Clinics, Other), By Players/Companies Bactiguard, R. Bard, Cook Medical, Davol, 3rd Stone Design, Teleflexorporated, Utah Medical Products, Becton Dickinson, Ge Healthcare, Inpress Technologies, Zoex Niasg”.
|Report Attributes||Report Details|
|Report Title||Postpartum Hemorrhage Treatment Device Market Research Report|
|By Type||Uterine Balloon Tamponade, Uniject Prefilled Injection System, Other|
|By Application||Hospitals, Clinics, Other|
|By Companies||Bactiguard, R. Bard, Cook Medical, Davol, 3rd Stone Design, Teleflexorporated, Utah Medical Products, Becton Dickinson, Ge Healthcare, Inpress Technologies, Zoex Niasg|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||231|
|Number of Tables & Figures||162|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Uterine Balloon Tamponade, Uniject Prefilled Injection System, Other and By Application Hospitals, Clinics, Other.
Some of the companies that are profiled in this report are:
Postpartum Hemorrhage Treatment Device Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Postpartum Hemorrhage Treatment Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Postpartum Hemorrhage Treatment Device Market Report:
Some other reports from this category!